Financhill
Back

Zomedica Quote, Financials, Valuation and Earnings

Zomedica Price Quote

$0.12
-0.01 (0%)
(Updated: December 21, 2024 at 5:55 AM ET)

Zomedica Key Stats

Sell
44
Zomedica (ZOM) is a Sell

Day range:
$0.12 - $0.13
52-week range:
$0.12 - $0.23
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.59
P/B ratio:
0.61%

Volume:
6.5M
Avg. volume:
6.8M
1-year change:
-39.23%
Market cap:
$122.8M
Revenue:
$25.2M
EPS:
$-0.07

How Much Does Zomedica Make?

Data Unavailable

Is Zomedica Growing As A Company?

Data Unavailable

Zomedica Stock Price Performance

  • Did Zomedica Stock Go Up Last Month?
    Zomedica share price went down by -4.5% last month
  • Did ZOM's Share Price Rise Over The Last Year?
    ZOM share price fell by -39.23% over the past 1 year

What Is Zomedica 52-Week High & Low?

  • What Is Zomedica’s 52-Week High Share Price?
    Zomedica has traded as high as $0.23 over the past 52 weeks
  • What Is Zomedica’s 52-Week Low Share Price?
    Zomedica has traded as low as $0.12 over the past 52 weeks

Zomedica Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Zomedica?

Data Unavailable

Is Zomedica Cash Flow Positive?

Data Unavailable

Zomedica Return On Invested Capital

Data Unavailable

Zomedica Earnings Date & Stock Price

  • What Is Zomedica's Stock Price Today?
    A single share of ZOM can be purchased today for 0.13
  • What Is Zomedica’s Stock Symbol?
    Zomedica trades on the nyam under the ticker symbol: ZOM
  • When Is Zomedica’s Next Earnings Date?
    The next quarterly earnings date for Zomedica is scheduled on April 1, 2025
  • When Is ZOM's next ex-dividend date?
    Zomedica's next ex-dividend date is December 22, 2024
  • How To Buy Zomedica Stock?
    You can buy Zomedica shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Zomedica Competitors

  • Who Are Zomedica's Competitors?
    Below is a list of companies who compete with Zomedica or are related in some way:
    • Adagio Medical Holdings Inc (ADGM)
    • Ainos Inc (AIMD)
    • Intelligent Bio Solutions Inc (INBS)
    • Standard BioTools Inc (LAB)
    • LENSAR Inc (LNSR)

Zomedica Dividend Yield

Data Unavailable

Zomedica Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 10.24% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable